StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report issued on Friday. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright lowered Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price objective for the company. in a report […]
StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research note released on Thursday morning. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut shares of Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price objective on the […]
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 79,900 shares, a decline of 18.9% from the January 15th total of 98,500 shares. Approximately 1.0% of the shares of the company […]
StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report published on Tuesday. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price target for the company. in a report […]
Research analysts at StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) in a research report issued on Tuesday. The brokerage set a “strong-buy” rating on the stock. Separately, HC Wainwright downgraded Taro Pharmaceutical Industries from a “buy” rating to a “neutral” rating and set a $43.00 price target on […]